Skip to main content
OpenTrials
Completed

NCT Number: NCT01156012

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

The purpose of this study is to assess the efficacy and safety of T2345 versus active comparator.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Medical Director

Clermont-Ferrand, 63000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients diagnosed with glaucoma

Exclusion criteria

  • Under 18.

Treatment and study plan

T2345

Drug

One drop of T2345

Prostaglandin

Drug

One drop

Primary outcomes

  1. Change From Baseline in Intraocular Pressure (IOP)

    Time frame: Day 0 and Day 84

    The worse eye is defined as:

    • If both eyes are eligible the eye with highest Intraocular pressure (IOP) at Day 0 (D0). If both eyes have the same IOP at D0 the worse eye is the right eye.
    • If only one eye is eligible this eye is the worse eye.
    • If neither eye is eligible the worse eye is defined as the eye with the highest IOP at D0.

    If both eyes have the same IOP at D0 the worse eye is the right eye.

Sponsors and collaborators

Lead sponsor

Laboratoires Thea

Industry

Registry information

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Jul 2, 2010
Registry last updated
Jan 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.